(Q40539998)

21 September 2017

Post-translational modification of Rta of Epstein-Barr virus by SUMO-1. (English)

1 reference

21 September 2017

0 references

Li-Kwan Chang

1

1 reference

21 September 2017

Yu-Hsiu Lee

2

1 reference

21 September 2017

Tai-Shan Cheng

3

1 reference

21 September 2017

Yi-Ren Hong

4

1 reference

21 September 2017

Pei-Jung Lu

5

1 reference

21 September 2017

Janng J Wang

6

1 reference

21 September 2017

Wen-Hung Wang

7

1 reference

21 September 2017

Chung-Wen Kuo

8

1 reference

21 September 2017

Steven S-L Li

9

1 reference

21 September 2017

Shih-Tung Liu

10

1 reference

21 September 2017

language of work or name

English

0 references

publication date

30 June 2004

1 reference

Journal of Biological Chemistry

21 September 2017

1 reference

21 September 2017

279

1 reference

21 September 2017

37

1 reference

21 September 2017

38803-38812

1 reference

SUMO--nonclassical ubiquitin

21 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

SP-RING for SUMO: new functions bloom for a ubiquitin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Characterization of a second member of the sentrin family of ubiquitin-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Molecular features of human ubiquitin-like SUMO genes and their encoded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Cloning and expression of human homolog HSMT3 to yeast SMT3 suppressor of MIF2 mutations in a centromere protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Ubch9 conjugates SUMO but not ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Involvement of PIAS1 in the sumoylation of tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

The nucleoporin RanBP2 has SUMO1 E3 ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

The polycomb protein Pc2 is a SUMO E3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

An E3-like factor that promotes SUMO conjugation to the yeast septins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Modification with SUMO. A role in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Transcription factor Sp3 is silenced through SUMO modification by PIAS1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Evaluation of interactions of human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

SUMO-1 modification of human cytomegalovirus IE1/IE72

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

EBNA3C coactivation with EBNA2 requires a SUMO homology domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Protein modification by SUMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Sumoylation of Smad4, the Common Smad Mediator of Transforming Growth Factor-β Family Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Sumoylation is involved in beta-catenin-dependent activation of Tcf-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405470200

21 January 2018

Identifiers

DOI

10.1074/JBC.M405470200

1 reference

21 September 2017

1 reference